See GRI Bio Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap

4.22M

Dividend TTM

0.00

P/E TTM

0.00

EPS TTM

-3.25K

Revenue

Net Profit

-10.12M

ROE

-185.67%

ROA

-141.84%

GRI Bio Inc Earnings Date

Latest Release

Aug 14, 2026

EPS / Forecast

-0.91/-1.20

Revenue / Forecast

--/0.00

Financial Statement Highlights

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

Financial Indicators

EPS

30.59%-0.91

72.23%-1.61

-68.57%-13.25

88.78%-1.28

98.43%-1.31

94.26%-5.80

98.92%-7.86

98.58%-11.42

98.06%-83.56

98.77%-101.04

87.25%-725.50

---801.55

---4.32K

---8.25K

---5.69K

----

Revenue

----

--0.00

----

--0.00

Net Profit

43.19%-1.64M

34.41%-2.00M

31.10%-2.66M

-58.22%-3.36M

-28.53%-2.89M

-61.42%-3.05M

-92.56%-3.86M

0.66%-2.12M

66.65%-2.25M

21.24%-1.89M

-26.60%-2.00M

-106.87%-2.14M

-280.49%-6.75M

9.07%-2.40M

48.87%-1.58M

17.82%-1.03M

23.31%-1.77M

0.11%-2.63M

-110.76%-3.10M

-20.29%-1.26M

Debt to assets ratio

----

--0.00%

----

--0.00%

----

Income Statement

Revenue

----

--0.00

----

--0.00

Operating profit

43.11%-1.65M

34.35%-2.00M

-36.34%-2.66M

-57.98%-3.37M

-28.36%-2.90M

-61.00%-3.05M

3.55%-1.95M

12.67%-2.13M

61.96%-2.26M

19.33%-1.90M

-46.28%-2.03M

-73.72%-2.44M

-294.02%-5.93M

10.82%-2.35M

55.24%-1.39M

-12.05%-1.40M

34.81%-1.51M

-1.23%-2.63M

-111.92%-3.09M

-21.30%-1.25M

Net Profit

43.19%-1.64M

34.41%-2.00M

31.10%-2.66M

-58.22%-3.36M

-28.53%-2.89M

-61.42%-3.05M

-92.56%-3.86M

0.66%-2.12M

66.65%-2.25M

21.24%-1.89M

-26.60%-2.00M

-106.87%-2.14M

-280.49%-6.75M

9.07%-2.40M

48.87%-1.58M

17.82%-1.03M

23.31%-1.77M

0.11%-2.63M

-110.76%-3.10M

-20.29%-1.26M

Balance Sheet

Current assets

103.26%11.33M

187.00%11.28M

53.02%8.59M

-11.76%4.70M

-19.00%5.58M

-11.25%3.93M

91.38%5.62M

21.89%5.32M

23.10%6.88M

111.16%4.43M

-29.34%2.93M

-21.58%4.37M

-28.66%5.59M

-63.57%2.10M

-48.92%4.15M

-43.84%5.57M

-31.27%7.84M

-59.85%5.76M

1106.08%8.13M

658.68%9.92M

Total current liabilities

-52.36%1.10M

-71.43%794.00K

61.55%2.64M

60.87%2.76M

4.20%2.31M

65.42%2.78M

-39.34%1.64M

-21.22%1.71M

38.15%2.22M

-18.68%1.68M

49.01%2.70M

3.18%2.18M

-62.89%1.60M

-18.60%2.07M

-25.97%1.81M

60.70%2.11M

158.65%4.32M

4.57%2.54M

9.89%2.44M

-7.14%1.31M

Total assets

100.53%11.38M

180.53%11.34M

51.00%8.67M

-12.40%4.78M

-19.29%5.67M

-11.88%4.04M

94.15%5.74M

23.96%5.46M

24.62%7.03M

118.74%4.59M

-28.81%2.96M

-20.92%4.40M

-29.54%5.64M

-64.72%2.10M

-50.19%4.15M

-45.08%5.57M

-31.25%8.01M

-59.29%5.94M

772.77%8.34M

530.99%10.14M

Total liabilities

-53.25%1.10M

-72.01%794.00K

55.71%2.66M

55.03%2.79M

1.77%2.35M

58.58%2.84M

-36.71%1.71M

-17.36%1.80M

44.14%2.31M

-13.41%1.79M

49.01%2.70M

3.18%2.18M

-63.05%1.60M

-20.05%2.07M

-28.09%1.81M

49.54%2.11M

141.97%4.34M

0.43%2.58M

4.48%2.52M

-13.49%1.41M

Total equity

209.45%10.28M

775.10%10.54M

49.01%6.01M

-45.55%1.99M

-29.60%3.32M

-56.93%1.21M

1456.76%4.03M

64.35%3.66M

16.86%4.72M

8925.81%2.80M

-88.94%259.00K

-35.62%2.23M

10.15%4.04M

-99.08%31.00K

-59.75%2.34M

-60.37%3.46M

-62.79%3.67M

-72.06%3.36M

500.14%5.82M

36470.83%8.73M

Cash Flow Statement

Net operating income

54.33%-1.45M

-112.27%-3.69M

-48.62%-2.97M

-1.98%-2.31M

-47.87%-3.17M

21.20%-1.74M

64.05%-2.00M

-73.00%-2.27M

-71266.67%-2.14M

-280.48%-2.20M

-305.54%-5.56M

29.21%-1.31M

99.82%-3.00K

74.72%-579.00K

13.39%-1.37M

-43.68%-1.85M

34.91%-1.62M

22.32%-2.29M

-95.92%-1.58M

-21.15%-1.29M

Net investment

----

---3.00K

----

--0.00

----

-100.00%0.00

-100.91%-8.00K

----

172.92%420.00K

140.78%1.33M

--876.00K

--1.15M

---576.00K

---3.27M

Net financing

-73.14%1.34M

59227.27%6.50M

213.37%7.15M

88.50%1.25M

13.72%5.01M

-100.25%-11.00K

-41.21%2.28M

--661.00K

-36.35%4.40M

335.53%4.49M

--3.88M

-100.00%0.00

102.02%6.92M

4578.26%1.03M

100.00%0.00

247.62%31.00K

12328.57%3.42M

-100.15%-23.00K

-228.57%-23.00K

-90.91%-21.00K

FAQs

What are the current assets of GRI Bio Inc?



According to GRI Bio Inc's FY2025 earnings report, its current assets were 8.59M, with a year-on-year change of 53.02.

What are the total assets of GRI Bio Inc?



According to GRI Bio Inc's FY2025 earnings report, its total assets of GRI Bio Inc were 8.67M, with a year-on-year change of 51.00.

What are the total liabilities of GRI Bio Inc?



According to GRI Bio Inc's FY2025 earnings report, its total liabilities of GRI Bio Inc were 2.66M, with a year-on-year change of 55.71.

What is the total equity of GRI Bio Inc?



According to GRI Bio Inc's FY2025 earnings report, its total equity of GRI Bio Inc was 6.01M, with a year-on-year change of 49.01.

What is the net operating income of GRI Bio Inc?



According to GRI Bio Inc's FY2025 earnings report, its net operating income of GRI Bio Inc was -11.98M, with a year-on-year change of -45.44.

What is the net financing of GRI Bio Inc?



According to GRI Bio Inc's FY2025 earnings report, its net financing of GRI Bio Inc was 13.39M, with a year-on-year change of 13.18.

What is the Earnings Per Share (EPS) of GRI Bio Inc?



According to GRI Bio Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3410.36, with a year-on-year change of -263.39.

What is the net income of GRI Bio Inc?



According to GRI Bio Inc's FY2025 earnings report, its net income was -11.96M, with a year-on-year change of -18.17.

What is the Return on Equity (ROE) of GRI Bio Inc?



According to GRI Bio Inc's FY2025 earnings report, its Return on Equity (ROE) was -238.17, with a year-on-year change of 49.50.

What is the Return on Assets (ROA) of GRI Bio Inc?



According to GRI Bio Inc's FY2025 earnings report, its Return on Assets (ROA) was -166.00, with a year-on-year change of 12.07.

What is the operating profit of GRI Bio Inc?



According to GRI Bio Inc's FY2025 earnings report, its operating profit was -11.98M, with a year-on-year change of -45.44.